Literature DB >> 17334854

Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease.

Yilong Ma1, David Eidelberg.   

Abstract

Brain imaging of cerebral blood flow and glucose metabolism has been playing key roles in describing pathophysiology of Parkinson's disease (PD) and Huntington's disease (HD), respectively. Many biomarkers have been developed in recent years to investigate the abnormality in molecular substrate, track the time course of disease progression, and evaluate the efficacy of novel experimental therapeutics. A growing body of literature has emerged on neurobiology of these two movement disorders in resting states and in response to brain activation tasks. In this paper, we review the latest applications of these approaches in patients and normal volunteers at rest conditions. The discussions focus on brain mapping studies with univariate and multivariate statistical analyses on a voxel basis. In particular, we present data to validate the reproducibility and reliability of unique spatial covariance patterns related with PD and HD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334854      PMCID: PMC4455550          DOI: 10.1007/s11307-007-0085-4

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  81 in total

1.  Functional imaging of sequence learning in Parkinson's disease.

Authors:  Maren Carbon; David Eidelberg
Journal:  J Neurol Sci       Date:  2006-06-05       Impact factor: 3.181

2.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

3.  Medication-induced hallucination and cerebral blood flow in Parkinson's disease.

Authors:  K Okada; N Suyama; H Oguro; S Yamaguchi; S Kobayashi
Journal:  J Neurol       Date:  1999-05       Impact factor: 4.849

4.  Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease.

Authors:  Xukui Wang; Aparajita Sarkar; Francesca Cicchetti; Meixiang Yu; Aijun Zhu; Kimmo Jokivarsi; Martine Saint-Pierre; Anna-Liisa Brownell
Journal:  J Neurol Sci       Date:  2005-01-28       Impact factor: 3.181

5.  Huntington's disease progression. PET and clinical observations.

Authors:  T C Andrews; R A Weeks; N Turjanski; R N Gunn; L H Watkins; B Sahakian; J R Hodges; A E Rosser; N W Wood; D J Brooks
Journal:  Brain       Date:  1999-12       Impact factor: 13.501

6.  18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis.

Authors:  Nacer Kerrouche; Karl Herholz; Rüdiger Mielke; Vjera Holthoff; Jean-Claude Baron
Journal:  J Cereb Blood Flow Metab       Date:  2006-03-08       Impact factor: 6.200

7.  The metabolic topography of parkinsonism.

Authors:  D Eidelberg; J R Moeller; V Dhawan; P Spetsieris; S Takikawa; T Ishikawa; T Chaly; W Robeson; D Margouleff; S Przedborski
Journal:  J Cereb Blood Flow Metab       Date:  1994-09       Impact factor: 6.200

8.  Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.

Authors:  M Otsuka; Y Ichiya; S Hosokawa; Y Kuwabara; T Tahara; T Fukumura; M Kato; K Masuda; I Goto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

9.  PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline.

Authors:  A B Young; J B Penney; S Starosta-Rubinstein; D S Markel; S Berent; B Giordani; R Ehrenkaufer; D Jewett; R Hichwa
Journal:  Ann Neurol       Date:  1986-09       Impact factor: 10.422

10.  MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

Authors:  L Mosconi; D Perani; S Sorbi; K Herholz; B Nacmias; V Holthoff; E Salmon; J-C Baron; M T R De Cristofaro; A Padovani; B Borroni; M Franceschi; L Bracco; A Pupi
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

View more
  24 in total

1.  Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism.

Authors:  Yilong Ma; Shichun Peng; Phoebe G Spetsieris; Vesna Sossi; David Eidelberg; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-30       Impact factor: 6.200

2.  Complex relationships between cerebral blood flow and brain atrophy in early Huntington's disease.

Authors:  J Jean Chen; David H Salat; H Diana Rosas
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

3.  Arterial spin labeling and altered cerebral blood flow patterns in the minimally conscious state.

Authors:  A A Liu; H U Voss; J P Dyke; L A Heier; N D Schiff
Journal:  Neurology       Date:  2011-09-21       Impact factor: 9.910

Review 4.  Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease.

Authors:  Shichun Peng; David Eidelberg; Yilong Ma
Journal:  Neurosci Bull       Date:  2014-09-28       Impact factor: 5.203

Review 5.  Functional neuroimaging in Parkinson's disease.

Authors:  Martin Niethammer; Andrew Feigin; David Eidelberg
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

6.  Glucose metabolism-weighted imaging with chemical exchange-sensitive MRI of 2-deoxyglucose (2DG) in brain: Sensitivity and biological sources.

Authors:  Tao Jin; Hunter Mehrens; Ping Wang; Seong-Gi Kim
Journal:  Neuroimage       Date:  2016-08-26       Impact factor: 6.556

7.  Monitoring Huntington's disease progression through preclinical and early stages.

Authors:  Chris Tang; Andrew Feigin
Journal:  Neurodegener Dis Manag       Date:  2012-08-01

Review 8.  Metabolic brain networks in neurodegenerative disorders: a functional imaging approach.

Authors:  David Eidelberg
Journal:  Trends Neurosci       Date:  2009-09-16       Impact factor: 13.837

9.  Parkinson's disease-related network topographies characterized with resting state functional MRI.

Authors:  An Vo; Wataru Sako; Koji Fujita; Shichun Peng; Paul J Mattis; Frank M Skidmore; Yilong Ma; Aziz M Uluğ; David Eidelberg
Journal:  Hum Brain Mapp       Date:  2016-05-21       Impact factor: 5.038

Review 10.  Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.

Authors:  S Klöppel; S M Henley; N Z Hobbs; R C Wolf; J Kassubek; S J Tabrizi; R S J Frackowiak
Journal:  Neuroscience       Date:  2009-01-29       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.